Sen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.
Related Posts
Anthropic to spend $50 billion on U.S. AI infrastructure, starting with Texas, New York data centers
Anthropic rival OpenAI has secured more than $1.4 trillion worth of deals with Nvidia, Broadcom, Oracle and the major cloud…
European Central Bank to make ‘last easy rate cut’ as tariffs, higher fiscal spending loom
Disagreement among policymakers may be set to increase as the neutral rate swims into view.
Elon Musk asks court to block OpenAI from converting to a for-profit
Elon Musk seeks to block OpenAI from changing its business structure, and discouraging deals to back competitors like xAI.